Company Filing History:
Years Active: 2010-2014
Title: Innovations of Inventor Li Zhang
Introduction
Li Zhang is a notable inventor based in Boyds, MD (US). He has made significant contributions to the field of biomedical research, particularly in the development of novel compositions and methods for medical applications. With a total of 2 patents, his work has the potential to impact various therapeutic areas.
Latest Patents
Li Zhang's latest patents include innovative compositions and methods utilizing fibrin beta chain fragments. One patent describes a composition that includes a peptide sequence corresponding to an amino acid sequence of a fibrin beta chain fragment. This composition may contain non-naturally occurring amino acid residues and is designed for use in treatment methods that may include a polypeptide agent such as Thymosin beta 4. Another patent focuses on integrin CD18 as a novel stromal stem cell marker, which is crucial for selecting a population of bone marrow stromal stem cells (BMSSCs). This invention outlines methods for isolating BMSSCs based on CD18 expression, which can be utilized in treating various diseases, particularly those related to bone degeneration.
Career Highlights
Li Zhang is affiliated with the University System of Maryland, where he conducts his research and development activities. His work is characterized by a strong emphasis on innovative solutions in the biomedical field, contributing to advancements in medical treatments and therapies.
Collaborations
Li Zhang has collaborated with notable colleagues, including Yasuo Miura and Songtao Shi. These collaborations have further enriched his research endeavors and have led to the development of impactful inventions.
Conclusion
Li Zhang's contributions to the field of biomedical research through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and therapies.